XENE compared with LLY: revenue, margins and what each company keeps, and the suppliers and customers both name

XENEXenon Pharmaceuticals Inc.

Mkt capRevenueRevenue

LLYELI Lilly & Co

Mkt capRevenueRevenue

Compare

XENEXenon Pharmaceuticals Inc.

LLYELI Lilly & Co

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Earnings history

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Earnings history

last 4 reports each · paired by recencyMethod ›

XENE

0 of 4at or beyond implied

Reportimpliedrealized× implied

Q2 FY26±9.1%▼−1.84%×0.20

May 8 '26±10.3%▲+0.79%×0.08

Q1 FY26±30.3%▼−3.76%×0.13

Nov 4 '25±8.7%▼−4.94%×0.56

LLY

3 of 4at or beyond implied

Reportimpliedrealized× implied

Q3 FY26±5.1%▲+6.63%×1.29

Q2 FY26±6.2%▲+4.86%×0.79

= impliedXENE realized, solidLLY realized, hatchedOne scale, both sides: full bar = 31%× = |realized| ÷ impliedSource: market data

Q1 FY26

±5.3%

▲+9.80%

×1.85

Feb 4 '26±6.1%▲+10.33%×1.69

XENEXenon Pharmaceuticals Inc.

37.69▼−3.84%· post 37.48

Mkt cap$3.8BRevenue$8MQ1 FY25Revenue—

LLYELI Lilly & Co

1,371.32▼−3.29%· post 1,363.77

ClosedNov 5 '26

Mkt cap$1.2TRevenue$24.4BQ3 FY26Revenue$65.2BFY25

Compare

ClosedNov 5 '26

XENEXenon Pharmaceuticals Inc.

LLYELI Lilly & Co

37.69▼−3.84%post 37.48

Price

1,371.32▼−3.29%post 1,363.77

$3.8B

Mkt cap

$1.2T

Q1 FY25$8M

Revenue

$24.4BQ3 FY26

—

Revenue

$65.2BFY25

XENE37.69▼−3.84%vsLLY1,371.32▼−3.29%ClosedNov 5 '26